Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children

The addition of blinatumomab after induction chemotherapy in children with standard-risk disease of average or high risk of relapse significantly improved disease-free survival.

​   The New England Journal of Medicine: Search Results in Pediatrics